Literature DB >> 15395948

The effect of theophylline ethylene diamine on renal function in control subjects and in patients with congestive heart failure.

J O DAVIS, N W SHOCK.   

Abstract

Entities:  

Keywords:  HEART; KIDNEYS; THEOPHYLLINE

Mesh：

Substances：

Year:  1949        PMID： 15395948      PMCID： PMC439702          DOI： 10.1172/JCI102211

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  6 in total

1.  THE MEASUREMENT OF THE TUBULAR EXCRETORY MASS, EFFECTIVE BLOOD FLOW AND FILTRATION RATE IN THE NORMAL HUMAN KIDNEY.

Authors:  H W Smith; W Goldring; H Chasis
Journal:  J Clin Invest       Date:  1938-05       Impact factor: 14.808

2.  RENAL AND CIRCULATORY FACTORS IN THE EDEMA FORMATION OF CONGESTIVE HEART FAILURE.

Authors:  A P Briggs; D M Fowell; W F Hamilton; J W Remington; N C Wheeler; J A Winslow
Journal:  J Clin Invest       Date:  1948-11       Impact factor: 14.808

3.  EDEMA AND DECREASED RENAL BLOOD FLOW IN PATIENTS WITH CHRONIC CONGESTIVE HEART FAILURE: EVIDENCE OF "FORWARD FAILURE" AS THE PRIMARY CAUSE OF EDEMA.

Authors:  A J Merrill
Journal:  J Clin Invest       Date:  1946-05       Impact factor: 14.808

4.  STUDIES ON THE ACTION OF DIURETICS I. THE EFFECT OF EUPHYLLIN AND SALYRGAN UPON GLOMERULAR FILTRATION AND TUBULAR REABSORPTION.

Authors:  H L Schmitz
Journal:  J Clin Invest       Date:  1932-11       Impact factor: 14.808

5.  RENAL PLASMA FLOW AND SODIUM REABSORPTION AND EXCRETION IN CONGESTIVE HEART FAILURE.

Authors:  R Mokotoff; G Ross; L Leiter
Journal:  J Clin Invest       Date:  1948-01       Impact factor: 14.808

6.  THE CONTROL OF RENAL BLOOD FLOW AND GLOMERULAR FILTRATION IN NORMAL MAN.

Authors:  H Chasis; H A Ranges; W Goldring; H W Smith
Journal:  J Clin Invest       Date:  1938-09       Impact factor: 14.808
  6 in total
  12 in total

1.  EFFECT OF DOPAMINE IN MAN: AUGMENTATION OF SODIUM EXCRETION, GLOMERULAR FILTRATION RATE, AND RENAL PLASMA FLOW.

Authors:  R H MCDONALD; L I GOLDBERG; J L MCNAY; E P TUTTLE
Journal:  J Clin Invest       Date:  1964-06       Impact factor: 14.808

2.  STUDIES OF EXPERIMENTAL RENAL FAILURE IN DOGS. I. EFFECT OF 5-6 NEPHRECTOMY ON CONCENTRATING AND DILUTING CAPACITY OF RESIDUAL NEPHRONS.

Authors:  J W COBURN; H C GONICK; M E RUBINI; C R KLEEMAN
Journal:  J Clin Invest       Date:  1965-04       Impact factor: 14.808

3.  Diuretics.

Authors:  G M WILSON
Journal:  Br Med J       Date:  1963-02-02

4.  The effects of salt restriction on the renal concentrating operation in normal, hydropenic man.

Authors:  R M STEIN; B H LEVITT; M H GOLDSTEIN; J G PORUSH; G M EISNER; M F LEVITT
Journal:  J Clin Invest       Date:  1962-12       Impact factor: 14.808

5.  Effect of meralluride on solute and water excretion in hydrated man: comments on site of action.

Authors:  M H GOLDSTEIN; M F LEVITT; A D HAUSER; D POLIMEROS
Journal:  J Clin Invest       Date:  1961-04       Impact factor: 14.808

6.  [Aldosterone, glomerular filtration and sodium retention].

Authors:  E BUCHBORN; K R KOCZOREK; H P WOLFF
Journal:  Klin Wochenschr       Date:  1959-01-15

7.  Mechanisms contributing to unresponsiveness to mecurial diuretics in congestive failure.

Authors:  R E WESTON; D J W ESCHER; J GROSSMAN; L LEITER
Journal:  J Clin Invest       Date:  1952-10       Impact factor: 14.808

8.  [The effect of aminophyllin on plasma volume in the healthy heart and in cardiac insufficiency in man].

Authors:  D CHACHUTOW; M SCHWAB
Journal:  Klin Wochenschr       Date:  1953-06-01

Review 9.  [Vasoactive substances belonging to the body and pharmacologic agents with peripheral point of application].

Authors:  E Muscholl
Journal:  Arch Klin Exp Ohren Nasen Kehlkopfheilkd       Date:  1967

10.  Population pharmacokinetics of theophylline during paediatric extracorporeal membrane oxygenation.

Authors:  Hussain Mulla; Fazal Nabi; Sanjiv Nichani; Graham Lawson; R K Firmin; David R Upton
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.